156 related articles for article (PubMed ID: 30861644)
1. [The value of preoperative CA19-9 combined with platelet-to-lymphocyte ratio in predicting invasive malignancy in intraductal papillary mucinous neoplasms].
Li JA; Han X; Fang Y; Zhang L; Lou WH; Xu XF; Wu WC; Kuang TT; Wang DS; Rong YF
Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):170-175. PubMed ID: 30861644
[No Abstract] [Full Text] [Related]
2. Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Gemenetzis G; Bagante F; Griffin JF; Rezaee N; Javed AA; Manos LL; Lennon AM; Wood LD; Hruban RH; Zheng L; Zaheer A; Fishman EK; Ahuja N; Cameron JL; Weiss MJ; He J; Wolfgang CL
Ann Surg; 2017 Aug; 266(2):339-345. PubMed ID: 27631774
[TBL] [Abstract][Full Text] [Related]
3. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW
J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
[TBL] [Abstract][Full Text] [Related]
4. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
5. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
6. Data analysis of 36 cases with intraductal papillary mucinous neoplasm of the pancreas for their clinicopathological features, diagnosis, and treatment.
Yuan C; Xiu D; Tao M; Ma Z; Jiang B; Li Z; Li L; Wang L; Wang H; Zhang T
Chin Med J (Engl); 2014; 127(23):4087-91. PubMed ID: 25430454
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
8. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
[TBL] [Abstract][Full Text] [Related]
9. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of tumor markers and biochemistry in the preoperative invasive assessment of intraductal papillary mucinous neoplasm of the pancreas.
You L; Ma L; Zhao WJ; Zhao YP; Dai MH
Clin Chim Acta; 2016 Feb; 454():89-93. PubMed ID: 26746574
[TBL] [Abstract][Full Text] [Related]
11. Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas.
Fritz S; Hackert T; Hinz U; Hartwig W; Büchler MW; Werner J
Br J Surg; 2011 Jan; 98(1):104-10. PubMed ID: 20949535
[TBL] [Abstract][Full Text] [Related]
12. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
[TBL] [Abstract][Full Text] [Related]
13. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kobayashi S; Kojima M; Miyauchi H; Asano T
J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540
[TBL] [Abstract][Full Text] [Related]
14. Are preoperative blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios useful in predicting malignancy in surgically-treated mucin-producing pancreatic cystic neoplasms?
Goh BK; Tan DM; Chan CY; Lee SY; Lee VT; Thng CH; Low AS; Tai DW; Cheow PC; Chow PK; Ooi LL; Chung AY
J Surg Oncol; 2015 Sep; 112(4):366-71. PubMed ID: 26280242
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic and prognostic values of inflammatory markers in intraductal papillary mucinous neoplasm.
Kim H; Jung W; Chan Shin Y; Han IW; Byun Y; Lee HW; Heo JS; Choi DW; Lim CS
HPB (Oxford); 2021 Oct; 23(10):1623-1628. PubMed ID: 34001453
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
17. Combined preoperative platelet-to-lymphocyte ratio and serum carbohydrate antigen 19-9 level as a prognostic factor in patients with resected pancreatic cancer.
Sakamoto T; Saito H; Amisaki M; Tokuyasu N; Honjo S; Fujiwara Y
Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):278-284. PubMed ID: 30987900
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas.
Qian Y; Gong Y; Luo G; Liu Y; Wang R; Zou X; Deng S; Lin X; Chen Y; Wang X; Yu X; Cheng H; Liu C
World J Surg Oncol; 2022 Sep; 20(1):310. PubMed ID: 36155113
[TBL] [Abstract][Full Text] [Related]
19. Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm.
Miyasaka Y; Ohtsuka T; Tamura K; Mori Y; Shindo K; Yamada D; Takahata S; Ishigami K; Ito T; Tokunaga S; Oda Y; Mizumoto K; Nakamura M; Tanaka M
Ann Surg; 2016 Jun; 263(6):1180-7. PubMed ID: 26334637
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]